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ABSTRACT
Objectives: To evaluate psychosocial influences and effects of breast cancer 
treatment. 
Design: Cohort questionnaire survey. 
Setting: Surgical Outpatient Department, Korle Bu Teaching Hospital (KBTH), Accra, 
Ghana. 
Subjects: Women previously treated for breast cancer, including those still on hormonal 
therapy. 
Main outcome measures: Perception of quality of treatment and psychosocial support; 
and patients’ felt needs for alternative treatment. 
Results: Eighty nine women treated one to 22 years previously were interviewed. 
The majority (86%) had mastectomy. Chemotherapy was the most unpleasant aspect 
of treatment in 58(65.2%), and 27 (30.3%) were not warned about complications of 
treatment. Thirty eight (42.7%) reported being afraid (frightened or terrified) at the 
diagnosis; other reactions were shock, devastation, weeping and depression. Twenty 
two (24.7%) received no counselling and 15 (18.5%) did not have opportunity to 
express their fears of death 55 (61.8%), mastectomy/deformity 27 (30.3%) and financial 
incapability 23 (25.8%). Forty four (49.4%) used alternate ‘treatment’, mainly prayer 
camps (25 cases) and herbs (22 cases), before and during hospital treatment. Use of 
alternate treatment led to delays in treatment in 23 women. They had complaints 
about the care they received: lack of sympathy and emotional support (16 cases), lack 
of information and communication (13 cases), lack of counselling (9 cases) and slow 
processes (8 cases). 
Conclusions: Many patients utilise prayer camps and herbs leading to delays in treatment. 
Breast cancer patients in Ghana (West Africa) are not receiving satisfactory emotional 
support, communication and counseling. Adequate psychosocial interventions need 
to be implemented. 
INTRODUCTION
Breast cancer is no longer an uncommon disease in 
developing countries. Cancer is the third commonest 
cause of hospital admissions in Ghana, after 
cardiovascular diseases and accidents/poisons (1); 
and breast cancer is the most common cancer in the 
country, accounting for 16% of all cancers documented 
at the Pathology Department of the Korle Bu Teaching 
Hospital (KBTH) (2). 
 Breast cancer has been shown to be associated 
with psychosocial problems and these may have an 
effect on prognosis (3). Patients with breast cancer 
go through severe emotional problems that may be 
related to their socioeconomic situation, psychological 
make-up and coping abilities, the medical parameters 
of the disease, the type of operation they undergo 
(mastectomy or lumpectomy), other forms of adjuvant 
treatment (chemotherapy, hormonal therapy or 
radiotherapy), the side effects of the treatment, and 
the availability of emotional and financial support 
(3-5). 
 In Ghana, as in many other countries, there is 
stigma and many misconceptions about the cause, 
treatment, outcome and other effects of the disease. 
These result in severe emotional trauma for patients 
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and probably contribute to delayed presentation: 60- 
70% of breast cancers in Ghana report at an advanced 
stage (6). 
 Most patients with breast complaints are seen 
at the general surgical outpatient clinics at the KBTH 
where the diagnosis of breast cancer is made after 
triple assessment. The clinics are busy, as the surgeons 
see cases with no appointment system in place. With 
medical students to be taught and emergencies to 
be attended to, patients are often given only a few 
minutes of the surgeon’s time. There is little time to 
engage in prolonged counselling. 
 Breast cancer,  being a heterogeneous 
disease, does not have one standard treatment; 
the treatment is customised to each patient and 
their tumour characteristics (7,8). The patients, 
therefore, sometimes have to be engaged in 
considering a range of options. They go through 
many investigations and see different specialists: 
surgeons, radiologists, and medical and radiation 
oncologists. They also have to attend anaesthetic 
clinics before surgery. Treatment takes many months 
or years and is often associated with complications. 
Patients are therefore necessarily bombarded with 
information about diagnosis, investigations and 
various modes of treatment. They sometimes have 
to consider treatment options and understand the 
implications and possible complications to the 
various treatments. It takes a long time for anyone 
to digest such information especially when it is 
associated with such emotional trauma, financial 
considerations and stigma that breast cancer 
patients have to contend with. 
 The cultural practices and other beliefs of 
Ghanaians sometimes add another dimension to the 
problem: because most of our patients prefer to let 
the doctor decide what is best for them and would 
rather have no input themselves, many patients end 
up with little information about the complexities of 
breast cancer treatment. Doctors who get accustomed 
to deciding for patients sometimes make the mistake 
of not giving breast cancer patients adequate 
information and explanation. 
 This study sought to assess the experiences and 
impressions of breast cancer survivors with regard 
to treatment obtained at the KBTH. The results of 
the study should help medical staff treating breast 
cancer patients from our socio-cultural background 
modify aspects of their care, and thus offer improved 
quality of care. 
MATERIALS AND METHODS
A questionnaire survey was carried out among 
women survivors who had completed breast cancer 
treatment and were attending follow-up clinics 
at the KBTH, after prior permission from hospital 
authorities. Questions were asked about types 
of treatment, counselling received and how they 
financed their treatment. They were asked about 
whether they were informed about complications of 
treatment. We also sought information about other 
(non-hospital treatment) they had sought and if that 
delayed any part of their hospital treatment. 
 Other questions dealt with the fears and anxieties 
they had at the time of diagnosis and whether they 
had opportunities to express those fears. Finally they 
were asked about what they did not like about hospital 
treatment and their suggestions for improved quality 
of care for breast cancer patients. 
 The questionnaires were administered by two 
nurses and two medical students on a mentorship 
programme. 
RESULTS
There were 89 women interviewed, aged between 28 
and 86 (mean 53.7, SD 11.7) years. Sixty three (70.8%) 
were married, seven (7.9%) were single, seven (7.9%) 
were divorced or separated and 12(13.5%) were 
widows. Most of them were active workers: 14 of 
the 27(30.3%) self-employed were traders. Others 17 
(19.1%) were in the hospitality industry, 14 (15.7%) 
professionals, eight (8.9%) office workers and six 
(6.74%) housewives. Fourteen (15.7%) were retired 
and only three (3.4%) said they were unemployed.  At 
the time they were diagnosed with breast cancer 54 
(60.7%) did not know of any breast cancer survivor. 
They knew it as a fatal disease. 
Educational status: Ten (11.2%) of those interviewed 
had no formal education, 17 (19.1%) had primary 
education, 39 (43.8%) had secondary education and 
23 (25.8%) had tertiary education. 
Treatment received: The patients were breast cancer 
survivors for periods that ranged from one year to 
22 years (mean 3.5 years). They had all completed 
their initial treatment, except those on hormonal 
(oral) treatment. 
Table 1 shows the treatments that patients had. 
No one in this series had received Trastuzumab 
immunotherapy. Chemotherapy was the most 
unpleasant part of the treatment for 58(65.2%), surgery 
for seven (7.9%), radiotherapy for seven (7.9%), the 
frequent hospital visits for three (3.4%) and hormonal 
therapy for one (1.1%). Nine (19.1%) found every 
aspect of the treatment unpleasant, and four (4.5%) 
did not find any part of the treatment unpleasant. 
Sixty two (69.7%) were warned about the complications 
of treatment but 27 (30.3%) were not. 
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Table 1
Treatment received by patients
Treatment  No.  (%) 
   
Mastectomy  78  87.6 
Bilateral mastectomy  1  1.1 
Lumpectomy  10  11.2 
Chemotherapy  85  95.5 
Radiotherapy  43  48.3 
Hormonal therapy  43  48.3 
Capecitabine  3  3.4
Reaction to diagnosis: Patients were informed about 
their diagnosis by the attending doctor in the 
consulting room. Their reaction to the news is 
summarised in their own words (Table 2). Sixty seven 
(75.3%) had received some counselling, but 22 (24.7%) 
had no counselling at all. 
Table 2
Patients’ reaction to diagnosis
Reaction to     
diagnosis No.  (%) 
Afraid, Terrified  38  42.7 
Shock  20  22.5 
Devastated  10  11.2 
Wept  9  10.1 
Depressed  6  6.7 
Disbelief  5  5.6 
Sad  5  5.6 
Lost appetite  4  4.5 
Insomnia  3  3.4 
Suicidal  1  1.1 
Nil, Indifference  10  11.2  
Patients’ fears: The fears patients had after being 
informed of their diagnosis is summarised in Table 
3. Not surprisingly the leading fears were the fear 
of death and mastectomy. Of the 81 who had fears, 
66(81.5%) had opportunity to express their fears, but 
15 (18.5%) had none. 
Table 3
Patients’ fears
Fears  No.  (%)
   
Death  55  61.8 
Mastectomy, Deformity  27  30.3 
Cost of treatment  23  25.8 
Uncertain future  9  10.1 
Job security  7  7.9 
Marriage security  5  5.6 
Stigmatisation  5  5.6 
Hospitalisation  5  5.6 
Alopecia  4  4.5 
Pain  3  3.4 
Others  2  2.2 
No fears  8  9.0
Non-hospital treatment: Forty four patients (49.4%) 
made use of alternate non-hospital ‘treatment’ in 
an attempt to achieve cure of their cancer. Twenty 
three of them (52.3%) admitted that it led to delays 
in their treatment. The non-hospital means they 
resorted to were prayers and prayer camps by 
25 out of 44 (56.8%), herbs by 22 (50%), organic 
foods and food supplements by seven (15.9%), 
Chinese remedies in two (4.5%) and homeopathy 
in two (4.5%). Fifteen of them used more than one 
remedy. Of the 44 patients that used non-hospital 
treatment, 21 (47.7%) did so before they started 
hospital treatment. Six (13.6%) used them during 
hospital treatment, and five (11.4%) after their 
treatment. Four (9.1%) used non-hospital treatment 
before and during hospital treatment; eight (18.2%) 
before, during and after hospital treatment. 
Financing treatment: Many patients used their own 
resources but needed much help. Their sources of 
finance (Table 4) reveal their reliance on family and 
religious networks. 
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Table 4
Sources of finance
Source  No.  (%) 
   
Patient’s resources  62  68.7 
Relatives  47  52.8 
Spouse  28  31.5 
Church/Mosque  17  19.1 
Employer  16  18 
Friends 11 12.4 
Sold property  4  4.5 
Savings and 
Investments  3  3.4 
Children  3  3.4 
Social clubs  2  2.2 
Appeal for funds 1 1.1 
Areas of dissatisfaction: Sixty one of the 89 women were 
dissatisfied with their treatment. The complaints are 
listed in Table 5. 
Table 5
Areas of patients’ dissatisfaction 
Complaint No. 
Lack of sympathy and emotional support 16 
Lack of information and communication 13 
Lack of counselling 9 
Processes too slow 8 
Long wait for histology report 6 
Lack of financial support 2 




This group of survivors reveal women actively 
engaged in various occupations. Most of the illiterates 
were involved in trading activities and were bread 
winners of their families. It is known that, compared 
to Caucasians, women of African descent develop 
breast cancer at a younger age (6-9), when they are 
likely to be actively engaged in income generation. 
 There is stigma attached to having breast 
cancer in Ghana as in many other countries. Healthy 
individuals assign stigma and avoidance behaviour is 
directed at cancer patients (10). Because of this stigma, 
many patients keep the diagnosis to themselves. It 
is therefore not surprising that 60% of our women 
did not know of anyone who had survived breast 
cancer at the time of their diagnosis. This fuels the 
impression that breast cancer cannot be cured. 
 The number of patients who had mastectomy is 
high compared to what pertains in more developed 
countries. This can be partly explained by the 
advanced nature of tumours in our country. It also 
explains why as many as 95% of our patients had 
chemotherapy, although only 41% of breast cancers 
in Ghana show hormone receptor positivity (11). It is 
good to note that few patients in Ghana (48%) now 
receive hormonal therapy, perhaps an indication 
that most patients now have their hormone receptor 
status determined before treatment. This is a positive 
change from what was obtained a few years ago, when 
there were very few facilities for hormone receptor 
status determination, and all patients were prescribed 
Tamoxifen blindly (12). 
 A combination of factors - stigma of breast 
cancer, the fact that it is considered fatal, and 
the fears and misconceptions associated with the 
disease - is likely to generate a lot of anxiety and 
fear in patients when they are informed about the 
diagnosis of breast cancer. In other reports, breast 
cancer patients go through emotions of denial, feeling 
of injustice, guilt, failure, betrayal, bewilderment, 
powerlessness, isolation and doom (13,14). The main 
reactions of our patients to their diagnosis were fear 
(terror), shock, devastation, weeping and depression. 
These patients feel vulnerable. Their cultural beliefs 
might address their state of vulnerability leading 
to them turning to traditional healers (13). In this 
study about half of the patients used non-hospital 
‘treatment’ , mainly herbs and prayer camps. This 
large number of patients going to prayer camps and 
resorting to the use of herbs reflects patients’ beliefs, 
but also shows that we have failed to address their 
state of vulnerability. Our patients therefore need 
more counselling and tender loving care. In this 
study, however, many patients were not offered 
counselling at all. This needs to change. 
 The financial burden in breast cancer treatment 
is great and many patients cannot afford treatment. 
Efforts should be made by our health authorities to 
further subsidise the cost of the various treatments. 
 Main fears expressed by the women were: fear 
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of death (62% of women), fear of mastectomy and 
associated deformity (30%), and the inability to 
finance treatment (26%). The authors have constantly 
been confronted with a very common misconception 
in Ghana: that women who undergo mastectomy will 
die within a couple of years. This belief probably 
explains why the fear of death and mastectomy are 
the main fears that patients have. These fears may 
also explain why many patients with breast cancer in 
Ghana delay reporting to hospital for many months, 
abscond during neoadjuvant therapy when surgery 
is due (6), and resort to other therapies. Their aim 
appears to avoid surgery at all cost. 
 Patients should have the opportunity to express 
their fears, especially since it appears their fears affect 
how they avail themselves of hospital treatment. 
Unfortunately, as shown in this study, many of the 
patients were not given the opportunity to express 
their fears. 
 Many of the survivors (67%) had some 
dissatisfaction with the treatment they received. 
The suggestions they make need to be taken 
seriously. Incidentally it reflects the deficiencies 
already identified. The first area they identified was 
a lack of sympathy and emotional support. The 
second and third are about lack of information and 
communication, and inadequate counselling. These 
three account for 62% of the concerns raised. 
 In developed countries there is a lot of 
information available to women with breast cancer 
and it is men with breast cancer who might find that 
information is insufficient and inappropriate (15). Our 
women with breast cancer are not receiving enough 
information. Our men with breast cancer face a worse 
predicament. 
 How can the problem of inadequate counselling, 
communication and giving information to patients 
be addressed? Much time needs to be spent with 
these patients. This is often not possible in the busy 
out-patients’ clinic. The use of clinical psychologists, 
breast care nurses and breast survivor volunteers 
should be considered as part of the management 
of our breast cancer patients, as happens in 
more advanced countries. Other home-made 
interventions have to be considered to address 
the peculiar problems identified, like the resort 
to herbal treatment and prayer camps that lead to 
delayed treatment and absconding. Those of our 
patients who are literate or have literate friends and 
relatives should be given information leaflets about 
breast cancer and its treatment. They should also 
be given the telephone numbers of cancer support 
organisations and that of a contact person in case 
they have questions, difficulties, or are in need of 
clarification or encouragement. 
 The availability of psychosocial interventions, 
including emotional and financial support, have been 
found to be important in the psychological impact and 
emotional responses of breast cancer patients (3,16). 
From this study, these appear to be deficient in our 
practice. This preliminary study should serve as a basis 
of a more extensive study to determine the extent to 
which our patients with breast cancer are affected by 
the quality of care they receive, especially as regards 
emotional support, communication and counselling. 
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